Skip to content

Dossier · RDW · Dormant

RDW · Redwire Corporation · Stock research

Last analysed ·

Current thesis

Post-SpaceX-IPO space deflation has broken every support: RDW lost the ~$10.40 July shelf and prints ~$8.51, ~67% below the 5/28 record close. The $500M ATM is now ~59M shares (~25% of float) versus ~27M at its $18.57 June reference falling price makes the same raise more dilutive. $41.5M of H1 Marine Corps Stalker orders is real but too small against ~$850M of equity supply.

Invalidation trigger

A weekly close below $8 loses the 2026-07-18 low and confirms the next leg of the post-SpaceX-IPO downtrend; a Q2 guidance cut or a fresh capital raise disclosed alongside the 2026-08-12 print reinforces the break.

Thesis status

Open commitment catalyst in 11dscored if the trigger above fires How this is scored →

Latest analysis and events for RDW —

As of 2026-07-19, orbyd's latest analysis for Redwire Corporation (RDW): Post-SpaceX-IPO space deflation has broken every support: RDW lost the ~$10.40 July shelf and prints ~$8.51, ~67% below the 5/28 record close. The $500M ATM is now ~59M shares (~25% of float) versus ~27M at its $18.57 June reference falling price makes the same raise more dilutive. $41.5M of H1 Marine Corps Stalker orders is real but too small against ~$850M of equity supply.

Invalidation trigger: A weekly close below $8 loses the 2026-07-18 low and confirms the next leg of the post-SpaceX-IPO downtrend; a Q2 guidance cut or a fresh capital raise disclosed alongside the 2026-08-12 print reinforces the break.

Next dated event on file: — catalyst in 11d.

Current Thesis

The standing-aside read from mid-July has been paid out. RDW lost the ~$10.40 early-July shelf and traded $8.06–$8.76 on 2026-07-18, closing near $8.51 roughly 67% below the $25.90 record close of 2026-05-28 and a fresh cycle low. What makes this different from an ordinary drawdown is the reflexivity: the $500M at-the-market program (2026-06-09) was sized against a $18.57 reference price on 2026-06-08, implying ~27M new shares. At $8.51 the same $500M requires ~59M shares against the 238.8M outstanding as of 2026-06-08 the lower the stock goes, the more dilutive the same dollar raise becomes. Share count is already up ~146% year over year. The defense side is genuinely working: $21.5M of follow-on Stalker UAS orders from PAE RAS announced 2026-07-15 brought first-half AIR PMO awards to $41.5M, and backlog hit a record $498.1M (+71.1% YoY). But $41.5M of half-year drone orders does not offset an ~$850M equity facility overhanging a $2.0B market cap. The space-infrastructure narrative that carried this name into May is spent; the UAS narrative is real but too small to re-rate the equity yet. No base has formed.

Bullish and bearish views on Redwire Corporation

The model's bull view on Redwire Corporation (RDW), in brief: Defense orders are converting on schedule. The bear view: The ATM gets more dilutive as the stock falls. Both cases follow in full.

Bull Case

  • Defense orders are converting on schedule. $21.5M follow-on award from Portfolio Acquisition Executive Robotic Autonomous Systems for Advanced Stalker Block 30 navigation and standard systems (2026-07-15), stacked on $20M in Q1, for $41.5M of disclosed AIR PMO orders in H1 2026. The Marine Corps is upgrading a fleet of hundreds of in-service Stalker platforms a recurring, not one-off, order stream.
  • Record backlog with a defense mix shift. $498.1M at Q1 2026, +21.1% sequential and +71.1% YoY, split $359.7M Space and $138.4M Defense Tech. Management cited more than $350M of bookings across the prior two quarters.
  • Guidance reaffirmed against a collapsing tape. FY2026 revenue of $450–500M held at the Q1 report, implying ~41.6% growth at the midpoint off Q1's $97.0M (+57.9% YoY).
  • Margin trajectory improving. Q1 gross margin of 26.6%, up 11.9 points YoY and ~17 points sequentially the Edge Autonomy mix is arriving at higher margin than legacy space hardware.
  • Consensus sits far above spot. Seven analysts carried a Buy consensus with a ~$15.71 average target as of 2026-07-12, and Jefferies raised its target to $24 from $13 on 2026-06-22 even while cutting to Hold. Against ~$8.51 the gap is the widest of the cycle.
  • International UAS proof point. The Taiwan Coast Guard Penguin Mk2.5 VTOL award via Taiwan Color Optics (2026-06-30) established a non-US defense channel for the Edge Autonomy portfolio.

Bear Case

  • The ATM gets more dilutive as the stock falls. $500M at the current quote is ~59M shares, roughly 25% of the float, versus ~27M at the June reference price. Layered on the ~$350M May facility, this is continuous price-insensitive supply into every rally the mechanism behind the -8% session on 2026-06-25 and the ~17.5% single-day break in early July.
  • Growth is purchased, not earned. Q1 net loss of $76.5M (-$0.40 diluted) and adjusted EBITDA of -$9.2M on $97.0M of revenue. Revenue compounding near 58% while EBITDA stays negative means every incremental dollar of growth consumes equity.
  • Share count up ~146% YoY. Per-share value is being destroyed faster than enterprise value is being created; a $2.0B market cap on ~239M shares assumes the count stops rising, which the active ATM contradicts.
  • Fugazi Research's short thesis is being confirmed by the tape. "Lost In Space" (2026-06-12) and "Selling Space Fantasies. Printing Shares." (2026-06-29) were followed by a further ~35% decline. Reports whose central claim is dilution rarely lose while the issuer is actively selling stock.
  • The theme catalyst has passed. SpaceX's >$2T Nasdaq debut on 2026-06-12 (priced $135, traded to ~$161) was the event the basket front-ran; SPCX now absorbs space-exposure capital directly, and index sponsors declined a dedicated space index on 2026-06-05.
  • FY guidance requires a violent H2 ramp. Holding $450–500M off a $97.0M Q1 implies roughly $120M+ per remaining quarter. The 2026-08-12 print is the first hard test of that curve, and a trim to guidance at these levels would be met with no bid.

Setup & Price Structure

  • Peak-to-trough: $25.90 record close (2026-05-28) and a $26.64 52-week high to an $8.06 intraday low (2026-07-18) a ~69% drawdown in seven weeks with no meaningful counter-trend rally.
  • Every prior support has failed in sequence: the ~$15 mid-June pivot, the ~$10.40 early-July shelf, and now the $10 round number. There is no higher low anywhere on the chart since May.
  • The 2026-07-15 Marine Corps order produced a green session, not a reversal price closed the week back near the lows. Contract headlines are being absorbed by supply rather than repriced.
  • The mid-teens region ($13–16) is where the ATM was priced and marketed; any recovery into that band should be treated as a distribution zone until issuance visibly stops.
  • Consensus at ~$15.71 is roughly 85% above spot. A target that far above price on a falling stock is a stale-estimate artifact, not a floor.

Catalyst Calendar (next 30 days)

  • 2026-07-30 Final approval hearing, shareholder derivative settlement (preliminary approval 2026-06-18). Governance reforms with insurance-funded fees; clears the board-conduct overhang the short campaign flagged. Low dollar impact, real headline risk removal.
  • 2026-08-12 Q2 2026 earnings. The binary: whether the ~$850M raised converts into recognized revenue, whether FY $450–500M survives, and how many shares were actually issued under the ATM in the quarter. The 10-Q share count is the single most important number in the release.
  • Ongoing, undated Further AIR PMO / Stalker follow-on orders. A named DoD award with a stated dollar figure in the nine figures would be the first datapoint capable of outrunning the dilution math.

What Would Change Our Mind

  • A weekly close back above $13 on expanding volume after a higher low holds the first structural evidence buyers are absorbing ATM supply rather than being run over by it.
  • Explicit disclosure on 2026-08-12 that the ATM has been suspended, or that issuance under it was de minimis in Q2. Removing the supply mechanism is worth more to this equity than any single contract.
  • Adjusted EBITDA turning positive, or a credible bridge to it within FY2026 the -$9.2M Q1 figure is the number that forces the equity raises.
  • A defense award of $100M+ with a named customer and stated dollar value, which would reframe RDW as a UAS prime with a space division rather than a diluting space-infrastructure story.
  • Conversely, a Q2 guidance cut or a new capital raise announced alongside earnings confirms the funding treadmill and argues for materially lower lows.

Correlation Notes

  • Trades as the high-beta, highest-dilution expression of the space complex. Rocket Lab and Firefly faded through June alongside it, but RDW's decline has been roughly double the group's the difference is the equity issuance, not the sector.
  • SPCX is now a direct competitor for space-exposure flows. Capital that previously had to buy the small-cap basket for exposure can now own the category leader outright, which structurally de-rates the laggards.
  • The Edge Autonomy / Stalker business correlates with the drone and counter-UAS defense complex, which remains a live theme. That divergence a strengthening defense sub-narrative inside a deflating space wrapper is the core tension in the name, and only a sum-of-parts revaluation at earnings resolves it.
  • Heavy retail and short-interest participation means moves are amplified in both directions; position sizing discipline for battleground names applies, with a hard cap regardless of conviction.

Notes

  • Q2 earnings est. ~August 2026 first read on whether the ~$350M raise (~2026-05-06) converts to revenue; outside current 30d window.
  • retail squeeze → 1%/name cap applies if ever traded; deflation leg post-catalyst-kill is asymmetric downside.
  • Catalyst hinges on unscheduled SpaceX IPO; S&P rejected dedicated index 2026-06-05 no firm re-arm date.
  • Edge Autonomy = drone/UAS optionality; watch for a named DoD award with a dollar figure to flip headline→fundamental.
  • Do not chase green days until a clean higher-low base forms above the late-May breakout shelf.
  • Edge Autonomy UAS optionality is now converting: Taiwan Coast Guard Penguin Mk2.5 VTOL award 2026-06-30 is the first named-contract proof watch for a DoD award with a stated dollar figure as the substance-confirmation trigger.
  • $500M ATM (2026-06-09) + ~$350M raise (~2026-05-06) = ~$850M facility per Fugazi; continuous price-insensitive supply is the structural ceiling treat bounces into the low-$20s as ATM-distribution zones.
  • Retail/short battleground with heavy dilution → 1%/name cap discipline applies; recovery is unconfirmed until a higher-low base holds above the ~$15 mid-June low on absorbing volume.
  • Derivative settlement final approval hearing 2026-07-30 (governance reforms, insurance-funded fees) nearest dated catalyst; can clear the governance overhang Fugazi flagged.
  • Q2 earnings est. ~August 2026 first read on whether the ~$850M raised converts to recognized revenue; outside the current 30-day window.
  • Fugazi Research short campaign: 2026-06-12 'Lost In Space' + 2026-06-29 'Selling Space Fantasies. Printing Shares.' shares rose despite the second report, short thesis largely priced.
  • Space theme is late-stage: SpaceX >$2T IPO (2026-06-12) = peak mainstream coverage; SPCX now competes for space-exposure capital, pressuring diluting laggards like RDW.
  • $500M ATM (2026-06-09) + ~$350M May raise = continuous price-insensitive supply; treat every mid-teens bounce as an ATM distribution zone until share-count stabilizes in filings.
  • Old ~$15 recovery pivot decisively lost in early July; downtrend intact until a clean higher-low base holds above a reclaimed level on absorbing volume no averaging into weakness.
  • Fugazi Research short campaign (2026-06-12 'Lost In Space', 2026-06-29 'Selling Space Fantasies. Printing Shares.') is being validated ~30% further downside since the second report.
  • Edge Autonomy (acquired ~June 2025 for $925M) is the UAS/defense leg; watch for a named DoD/allied award WITH a stated dollar figure as the substance-confirmation trigger the Taiwan Coast Guard headline lacked one.
  • Q1 2026: revenue $97.0M (+57.9% YoY) but gross margin 9.2%, EBIT ~-77%, net loss ~-$76.5M (-$0.40 EPS), ~$145M cash; FY2026 guide reaffirmed $450-500M. Fast growth funded by equity issuance is the core bear structure.
  • Derivative settlement final approval hearing 2026-07-30 governance-clearing, insurance-funded fees; nearest dated catalyst, modest price impact.
  • Q2 2026 earnings est. ~August first read on whether the ~$850M raised + Edge Autonomy backlog convert to recognized revenue and narrower losses; outside current 30d window.
  • Heavily shorted, retail-active battleground with live ATM → 1%/name cap discipline on any probe; post-catalyst deflation leg is asymmetric downside.
  • Prior $10 invalidation level triggered price traded $8.06–$8.76 on 2026-07-18, closing ~$8.51. Downtrend confirmed, no higher low since May.
  • Q2 2026 earnings confirmed 2026-08-12 first read on whether the ~$850M raised converts to recognized revenue and how many ATM shares were actually issued in Q2. The 10-Q share count is the key number.
  • ATM dilution math scales inversely with price: $500M = ~27M shares at the 2026-06-08 reference of $18.57, ~59M shares at ~$8.51. Reflexive downside mechanism, not a static overhang.
  • Shares outstanding 238,825,345 as of 2026-06-08; share count up ~146% YoY.
  • Record backlog $498.1M at Q1 2026 (+71.1% YoY): Space $359.7M, Defense Tech $138.4M. FY2026 guide $450–500M reaffirmed, requires ~$120M+ per remaining quarter off a $97.0M Q1.
  • Q1 2026: revenue $97.0M (+57.9% YoY), gross margin 26.6% (+11.9pts YoY), adjusted EBITDA -$9.2M, net loss -$76.5M (-$0.40 diluted).
  • Defense/UAS leg is the live sub-narrative: $21.5M PAE RAS follow-on (2026-07-15), $20M in Q1, $41.5M H1 AIR PMO total; Taiwan Coast Guard Penguin Mk2.5 (2026-06-30). Needs a $100M+ named award to outrun dilution math.
  • Derivative settlement final approval hearing 2026-07-30 (governance reforms, insurance-funded fees) clears the governance overhang Fugazi flagged; low dollar impact.
  • Retail/short battleground with heavy dilution → hard 1%/name cap applies if ever traded.
  • Consensus ~$15.71 (7 analysts, as of 2026-07-12) and Jefferies $24 PT (2026-06-22) are ~85%+ above spot stale estimates, not support.
  • Treat any recovery into the $13–16 band as an ATM distribution zone until issuance visibly stops.
  • Space-infrastructure leg is post-peak: SpaceX >$2T debut 2026-06-12 was the terminal catalyst; SPCX now absorbs space-exposure capital directly. S&P declined a dedicated space index 2026-06-05.

Related · shared themes

MRCY

Mercury Systems Inc

Defense-electronics turnaround re-rating inside an accelerating modernization tape: Q3 FY26 (2026-05-06) printed record bookings $348M (+73.7% YoY), 1.48 book-to-bill, record ~$1.6B backlog and +46% EBITDA, with FCF guided positive. But the stock just reversed ~16% off its $128.45 ATH; the ~2026-08-10 Q4/full-year print is the next binary.

MEDIUM

IRDM

Iridium Communications Inc

Narrative-momentum thesis is closed: Rocket Lab agreed 2026-06-29 to acquire Iridium for ~$54/share ($27 cash + a calculated ratio of RKLB stock), EV ~$8B. IRDM now trades as merger-arb spread to ~$54 plus embedded RKLB beta not on NTN Direct or spectrum. Morgan Stanley's PT-to-$54 (2026-06-30) confirms the Street marks it to the deal. Upside is capped at terms; the live binary is deal close vs. break on a 6–12 month regulatory clock.

LOW

ASTS

AST SpaceMobile, Inc.

The July 15-16 $1B convertible plus the slip of initial commercial direct-to-device service into 2027 broke the "2H26 revenue" leg the June rebound was built on; a 17% one-day flush to $55.01 and a fading +12% bounce mark this as a funded-but-delayed story trading on retail flow, with the 7/22 FCC licensing vote the only near-term catalyst.

LOW

PL

Planet Labs PBC

The post-SpaceX-IPO unwind has extended, not stabilized: PL broke the $23 shelf on the 7/16 -7.8% flush and trades ~$22.58, roughly 56% off the $51.40 May peak, with the 50-DMA ($35.40) and 200-DMA ($30.60) far overhead. Record fundamentals sit under a $1.5B at-the-market program now equal to ~19% of a $7.9B cap. Downtrend intact; no base, no bid worth chasing.

LOW

See also · stocks to watch